Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-07T23:31:43.093Z Has data issue: false hasContentIssue false

Interstage somatic growth in children with hypoplastic left heart syndrome after initial palliation with the hybrid procedure

Published online by Cambridge University Press:  08 April 2016

Fiona T. S. Chan*
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
Hannah R. Bellsham-Revell
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
Hannah Duggan
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
John M. Simpson
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
Tony Hulse
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
Aaron J. Bell
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
*
Correspondence to: F. T. S. Chan, Department of Congenital Heart Disease, Evelina London Children’s Hospital, Westminster Bridge Road, London SE1 7EH, United Kingdom. Tel: +44 020 7188 7188; Fax: +44 020 7188 4556; E-mail: F.Chan@nhs.net
Rights & Permissions [Opens in a new window]

Abstract

Introduction

The hybrid procedure is one mode of initial palliation for hypoplastic left heart syndrome. Subsequently, patients proceed with either the “three-stage” pathway – comprehensive second stage followed by Fontan completion – or the “four-stage” pathway – Norwood procedure, hemi-Fontan, or Fontan completion. In this study, we describe somatic growth patterns observed in the hybrid groups and a comparison primary Norwood group.

Methods

A retrospective analysis of patients who have undergone hybrid procedure and Fontan completion was performed. Weight-for-age and height-for-age z-scores were recorded at each operation.

Results

We identified 13 hybrid patients – eight in the three-stage pathway and five in the four-stage pathway – and 49 Norwood patients. Weight: three stage: weight decreased from hybrid procedure to comprehensive second stage (−0.4±1.3 versus −2.3±1.4, p<0.01) and then increased to Fontan completion (−0.4±1.5 versus −0.6±1.4, p<0.01); four stage: weight decreased from hybrid procedure to Norwood (−2.0±1.4 versus −3.3±0.9, p=0.06), then stabilised to hemi-Fontan. Weight increased from hemi-Fontan to Fontan completion (−2.7±0.6 versus −1.0±0.7, p=0.01); primary Norwood group: weight decreased from Norwood to hemi-Fontan (p<0.001) and then increased to Fontan completion (p<0.001). Height: height declined from hybrid procedure to Fontan completion in the three-stage group. In the four-stage group, height decreased from hybrid to hemi-Fontan, and then increased to Fontan completion. The Norwood group decreased in height from Norwood to hemi-Fontan, followed by an increase to Fontan completion.

Conclusion

In this study, we show that patients undergoing the hybrid procedure have poor weight gain before superior cavopulmonary connection, before returning to baseline by Fontan completion. This study identifies key periods to target poor somatic growth, a risk factor of morbidity and worse neurodevelopmental outcomes.

Information

Type
Original Articles
Copyright
© Cambridge University Press 2016 
Figure 0

Figure 1 The three-stage pathway and time points.

Figure 1

Figure 2 The four-stage pathway and time points.

Figure 2

Table 1 Patient population.

Figure 3

Table 2 Baseline co-morbidities.

Figure 4

Table 3 Weight and weight z-scores.

Figure 5

Table 4 Height and height z-scores.

Figure 6

Figure 3 Graph demonstrating changes in weight-for-age z-score in the three-stage, four-stage, and primary Norwood groups. Significant changes are indicated with asterisks. SCPC=superior cavopulmonary connection; TCPC=total cavopulmonary connection.